Nao Suzuki Selected Research

Nao Suzuki Research Topics

Disease

55	Neoplasms (Cancer) 05/2024 - 09/2004
18	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 11/2004
12	Carcinoma (Carcinomatosis) 01/2022 - 09/2004
8	Clear Cell Adenocarcinoma 02/2010 - 09/2004
7	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2009
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2009
6	Infertility (Sterility) 05/2023 - 10/2013
6	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2004
6	Ovarian Epithelial Carcinoma 11/2021 - 09/2004
4	Periodontitis 12/2020 - 01/2012
3	Halitosis 01/2014 - 12/2008
3	Body Weight (Weight, Body) 01/2010 - 01/2010
2	Residual Neoplasm 06/2023 - 11/2020
2	Neuroendocrine Carcinoma 01/2023 - 08/2020
2	Fallopian Tube Neoplasms 03/2021 - 06/2016
2	Seizures (Absence Seizure) 08/2020 - 07/2008
2	Uterine Cervical Dysplasia 08/2017 - 03/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2017 - 03/2012
2	Arthralgia (Joint Pain) 01/2016 - 12/2013
2	Anorexia 01/2016 - 12/2013
2	Neutropenia 01/2016 - 12/2009
2	Diarrhea 01/2016 - 12/2009
2	Nausea 01/2016 - 12/2013
2	Hemorrhage 10/2013 - 08/2010
2	Leukemia 07/2013 - 03/2009
2	Epilepsy (Aura) 03/2013 - 09/2012
2	Tuberous Sclerosis (Bourneville's Disease) 03/2013 - 09/2012
2	Suppuration 03/2011 - 01/2009
2	Periodontal Pocket (Periodontal Pockets) 08/2010 - 12/2008
2	Adenocarcinoma 01/2006 - 10/2004
1	Transient Tachypnea of the Newborn 11/2023
1	Symptom Flare Up 10/2023
1	Insulin Resistance 10/2023
1	Insulinoma 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2022
1	Leigh Disease (Leigh's Disease) 05/2022
1	Primary Ovarian Insufficiency 01/2022
1	Endometriosis 01/2022
1	Placenta Accreta 01/2022

Drug/Important Bio-Agent (IBA)

8	Paclitaxel (Taxol)FDA LinkGeneric 03/2021 - 09/2004
8	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 09/2004
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2006
4	Messenger RNA (mRNA)IBA 09/2022 - 01/2006
4	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 03/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 12/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 09/2004
3	Aromatase InhibitorsIBA 03/2023 - 01/2018
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2020 - 12/2009
3	Sulfhydryl Compounds (Thiols)IBA 01/2018 - 12/2008
3	Polysaccharides (Glycans)IBA 08/2017 - 10/2007
3	ParaffinIBA 08/2017 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 08/2017 - 06/2013
3	Formaldehyde (Formol)FDA Link 08/2017 - 10/2007
3	Antineoplastic Agents (Antineoplastics)IBA 02/2010 - 09/2004
3	Small Interfering RNA (siRNA)IBA 02/2010 - 02/2009
3	Monoclonal AntibodiesIBA 10/2007 - 10/2004
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 07/2008
2	Estrogens (Estrogen)FDA Link 03/2023 - 01/2018
2	InterleukinsIBA 01/2023 - 11/2003
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 02/2015
2	TubulinIBA 09/2022 - 02/2009
2	Ceruloplasmin (Ferroxidase)IBA 01/2022 - 03/2014
2	PlatinumIBA 11/2021 - 11/2020
2	liposomal doxorubicin (Doxil)FDA Link 11/2021 - 03/2013
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2018 - 10/2013
2	EnzymesIBA 01/2018 - 09/2004
2	LectinsIBA 08/2017 - 03/2014
2	nedaplatinIBA 12/2013 - 06/2009
2	trans-sodium crocetinate (crocetin)IBA 03/2013 - 09/2012
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2011 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 02/2010 - 11/2009
2	taxaneIBA 12/2009 - 02/2009
2	AcidsIBA 08/2009 - 09/2004
2	RetinoidsIBA 03/2008 - 09/2004
2	TAC 101IBA 03/2008 - 09/2004
2	Benzoic Acid (Potassium Benzoate)FDA Link 03/2008 - 09/2004
2	Immunoglobulin M (IgM)IBA 11/2004 - 10/2004
1	Surface Antigens (Surface Antigen)IBA 06/2023
1	Complement System Proteins (Complement)IBA 06/2023
1	Coloring Agents (Dyes)IBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	ORALIT (ORS)IBA 12/2022
1	Growth Differentiation Factor 9IBA 09/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2022
1	wisteria lectinIBA 01/2022

Therapy/Procedure

29	Therapeutics 05/2023 - 10/2004
24	Drug Therapy (Chemotherapy) 10/2023 - 02/2009
6	Radiotherapy 07/2021 - 06/2009
5	Aftercare (After-Treatment) 05/2024 - 06/2016
4	Cesarean Section (Caesarean Section) 11/2023 - 07/2020
3	Transplantation 01/2022 - 07/2013
3	Hysterectomy 07/2021 - 06/2009
2	Salpingo-oophorectomy 03/2021 - 03/2011
2	Gynecologic Surgical Procedures (Gynecologic Surgery) 03/2021 - 11/2005
2	Laparotomy 03/2021 - 03/2011
2	Palliative Care (Palliative Therapy) 10/2016 - 06/2016
2	Blood Transfusion (Blood Transfusions) 11/2010 - 11/2005
1	Transitional Care 02/2024
1	Ambulatory Care (Outpatient Care) 10/2023
1	Contraception (Birth Control) 05/2022